Selected research
Industry Research
Nitroglycerin for Angina Industry Research Report 2026
Market perspective
The global Nitroglycerin for Angina market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nitroglycerin for Angina is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nitroglycerin for Angina is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nitroglycerin for Angina is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nitroglycerin for Angina include Sandoz, Mylan, Pfizer, Us Pharma, Sigmapharm Laboratories, Hercon Pharmaceuticals, Glenmark, Espero Pharmaceuticals and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nitroglycerin for Angina market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nitroglycerin for Angina Market by Company
Sandoz
Mylan
Pfizer
Us Pharma
Sigmapharm Laboratories
Hercon Pharmaceuticals
Glenmark
Espero Pharmaceuticals
Dr. Reddy's Laboratories
Nitroglycerin for Angina Segment by Type
Transdermal
Tablet
Powder
Nitroglycerin for Angina Segment by Application
Relief
Prophylaxis
Nitroglycerin for Angina Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitroglycerin for Angina market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitroglycerin for Angina and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitroglycerin for Angina.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nitroglycerin for Angina manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nitroglycerin for Angina by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nitroglycerin for Angina in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Transdermal
- Tablet
- Powder
Applications
- Relief
- Prophylaxis
Companies covered
- Sandoz
- Mylan
- Pfizer
- Us Pharma
- Sigmapharm Laboratories
- Hercon Pharmaceuticals
- Glenmark
- Espero Pharmaceuticals
- Dr. Reddy's Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nitroglycerin for Angina Market Size (2021-2032)
- 2.2.2 Global Nitroglycerin for Angina Sales (2021-2032)
- 2.2.3 Global Nitroglycerin for Angina Market Average Price (2021-2032)
- 2.3 Nitroglycerin for Angina by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Transdermal
- 2.3.3 Tablet
- 2.3.4 Powder
- 2.4 Nitroglycerin for Angina by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Relief
- 2.4.3 Prophylaxis
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nitroglycerin for Angina Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nitroglycerin for Angina Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Nitroglycerin for Angina Revenue of Manufacturers (2021-2026)
- 3.4 Global Nitroglycerin for Angina Average Price by Manufacturers (2021-2026)
- 3.5 Global Nitroglycerin for Angina Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nitroglycerin for Angina, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nitroglycerin for Angina, Product Type & Application
- 3.8 Global Manufacturers of Nitroglycerin for Angina, Established Date
- 3.9 Global Nitroglycerin for Angina Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sandoz
- 4.1.1 Sandoz Company Information
- 4.1.2 Sandoz Business Overview
- 4.1.3 Sandoz Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sandoz Nitroglycerin for Angina Product Portfolio
- 4.1.5 Sandoz Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Nitroglycerin for Angina Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Nitroglycerin for Angina Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Us Pharma
- 4.4.1 Us Pharma Company Information
- 4.4.2 Us Pharma Business Overview
- 4.4.3 Us Pharma Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Us Pharma Nitroglycerin for Angina Product Portfolio
- 4.4.5 Us Pharma Recent Developments
- 4.5 Sigmapharm Laboratories
- 4.5.1 Sigmapharm Laboratories Company Information
- 4.5.2 Sigmapharm Laboratories Business Overview
- 4.5.3 Sigmapharm Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sigmapharm Laboratories Nitroglycerin for Angina Product Portfolio
- 4.5.5 Sigmapharm Laboratories Recent Developments
- 4.6 Hercon Pharmaceuticals
- 4.6.1 Hercon Pharmaceuticals Company Information
- 4.6.2 Hercon Pharmaceuticals Business Overview
- 4.6.3 Hercon Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hercon Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 4.6.5 Hercon Pharmaceuticals Recent Developments
- 4.7 Glenmark
- 4.7.1 Glenmark Company Information
- 4.7.2 Glenmark Business Overview
- 4.7.3 Glenmark Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Glenmark Nitroglycerin for Angina Product Portfolio
- 4.7.5 Glenmark Recent Developments
- 4.8 Espero Pharmaceuticals
- 4.8.1 Espero Pharmaceuticals Company Information
- 4.8.2 Espero Pharmaceuticals Business Overview
- 4.8.3 Espero Pharmaceuticals Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Espero Pharmaceuticals Nitroglycerin for Angina Product Portfolio
- 4.8.5 Espero Pharmaceuticals Recent Developments
- 4.9 Dr. Reddy's Laboratories
- 4.9.1 Dr. Reddy's Laboratories Company Information
- 4.9.2 Dr. Reddy's Laboratories Business Overview
- 4.9.3 Dr. Reddy's Laboratories Nitroglycerin for Angina Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy's Laboratories Nitroglycerin for Angina Product Portfolio
- 4.9.5 Dr. Reddy's Laboratories Recent Developments
5 Global Nitroglycerin for Angina Market Scenario by Region
- 5.1 Global Nitroglycerin for Angina Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nitroglycerin for Angina Sales by Region: 2021-2032
- 5.2.1 Global Nitroglycerin for Angina Sales by Region: 2021-2026
- 5.2.2 Global Nitroglycerin for Angina Sales by Region: 2027-2032
- 5.3 Global Nitroglycerin for Angina Revenue by Region: 2021-2032
- 5.3.1 Global Nitroglycerin for Angina Revenue by Region: 2021-2026
- 5.3.2 Global Nitroglycerin for Angina Revenue by Region: 2027-2032
- 5.4 North America Nitroglycerin for Angina Market Facts & Figures by Country
- 5.4.1 North America Nitroglycerin for Angina Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nitroglycerin for Angina Sales by Country (2021-2032)
- 5.4.3 North America Nitroglycerin for Angina Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Nitroglycerin for Angina Market Facts & Figures by Country
- 5.5.1 Europe Nitroglycerin for Angina Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nitroglycerin for Angina Sales by Country (2021-2032)
- 5.5.3 Europe Nitroglycerin for Angina Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Nitroglycerin for Angina Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nitroglycerin for Angina Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nitroglycerin for Angina Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nitroglycerin for Angina Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nitroglycerin for Angina Market Facts & Figures by Country
- 5.7.1 South America Nitroglycerin for Angina Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nitroglycerin for Angina Sales by Country (2021-2032)
- 5.7.3 South America Nitroglycerin for Angina Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Nitroglycerin for Angina Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nitroglycerin for Angina Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nitroglycerin for Angina Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nitroglycerin for Angina Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Nitroglycerin for Angina Sales by Type (2021-2032)
- 6.1.1 Global Nitroglycerin for Angina Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Nitroglycerin for Angina Sales Market Share by Type (2021-2032)
- 6.2 Global Nitroglycerin for Angina Revenue by Type (2021-2032)
- 6.2.1 Global Nitroglycerin for Angina Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nitroglycerin for Angina Revenue Market Share by Type (2021-2032)
- 6.3 Global Nitroglycerin for Angina Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nitroglycerin for Angina Sales by Application (2021-2032)
- 7.1.1 Global Nitroglycerin for Angina Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Nitroglycerin for Angina Sales Market Share by Application (2021-2032)
- 7.2 Global Nitroglycerin for Angina Revenue by Application (2021-2032)
- 7.2.1 Global Nitroglycerin for Angina Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nitroglycerin for Angina Revenue Market Share by Application (2021-2032)
- 7.3 Global Nitroglycerin for Angina Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nitroglycerin for Angina Value Chain Analysis
- 8.1.1 Nitroglycerin for Angina Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nitroglycerin for Angina Production Mode & Process
- 8.2 Nitroglycerin for Angina Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nitroglycerin for Angina Distributors
- 8.2.3 Nitroglycerin for Angina Customers
9 Global Nitroglycerin for Angina Analyzing Market Dynamics
- 9.1 Nitroglycerin for Angina Industry Trends
- 9.2 Nitroglycerin for Angina Industry Drivers
- 9.3 Nitroglycerin for Angina Industry Opportunities and Challenges
- 9.4 Nitroglycerin for Angina Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst